AptadelTx

Spin-off founded for the development RNA therapeutics to treat childhood cancer

[diariARA @diariARA]

Aptadel Therapeutics capta 2 M€ per desenvolupar el seu fàrmac contra el sarcoma d'Ewing https://t.co/UICeysowPC

[Biotech-Spain.com @Biotech_Spain]

.@PCB_UB : @aptadel raises 2 million euros and prepares a new round to bring the project to the clinical phase stage https://t.co/CUaltdL68v

[Capital-Riesgo.es @CapitalRiesgo1]

. @aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage https://t.co/Cbi4eWJTWG

[@CDTI_innovacion @CDTI_innovacion]

🧬 La #innovación impulsa nuevas soluciones en el ámbito terapéutico

🤝Con #AyudasCDTI y los #FondosEuropeos #MRR impulsamos proyectos como el de @aptadel

🔬Desarrollo de una plataforma de aptámeros conjugados con #RNAS terapéuticos para nuevas estrategias frente al #cáncer 👉 https://t.co/k9nMn2I3Pu

💡Apoyando con ayudas #NEOTEC: https://t.co/6uDsFJW7cY

@CienciaGob @P_Recuperacion
#AyudandoCrearFuturo #nextgenerationeu #MRR #PRTR #subvención #tecnología #innovación #salud #Agenda2030 #ODS3

[BIOSPAIN @BIOSPAIN_AseBio]

🟢 Dr. Gisela Lorente, CEO, @aptadel
🟢 Dr. Héctor Pérez Montoyo, COO & Head of R&D, @AbilityPharma
🟢 @jordifabrega, Co-Founder & CEO, @ConnectaThx

[Biocat @biocat_bioregio]

@aptadel @TR_Qrem Tolemy bio

The present and the future of biotech at @BIOSPAIN_AseBio #BIOSPAIN25

[IDIBELL @idibell_cat]

New investment in research on Ewing's sarcoma‼️

IDIBELL's spin-off @aptadel Therapeutics receives funding from @LittleWarriorFd to develop RNA-based molecules🧬to find alternative treatments that are more effective and less toxic than current ones

More: https://t.co/fnj6DLudT3

[Catalonia.Health @CataloniaHealth]

🟢 Top news of #CataloniaHealth on January 2025🔝 https://t.co/HDlHJd4cdz

@_vitalera
@aptadel
@Ship2BVentures

#WeAreCataloniaHealth

[canSERV @canSERV_EU]

#canSERV_Userstories
Adrian Torres is Head of R&D at @aptadel, which develops RNA-based therapeutics for paediatric cancers. With canSERV’s support, they are spearheading the clinical development.

Explore how canSERV can advance YOUR own research.

➡️https://t.co/R1XCevwiKN

[anastasia khvorova @anastasiakhvor2]

List of approved RNA based drugs

[Parc Científic de Barcelona @PCB_UB]

#PCBCommunity | Gisela Lorente, cofounder & former CSO of @Aptadel is appointed new company CEO

The #spinoff from @idibell_cat focuses on developing #RNAtherapies platform for #childhoodcancer using #aptamer technology

@SRGIDIBELL @omt2007 @As_AlbaPerez

https://t.co/fsfd13yBnr

[Biocat @biocat_en]

@aptadel @Dannabiotech @mimarkdx @zymvol @onechaintx @nmarti1212 @BIOSPAIN_AseBio @PCB_UB @barcelonactiva @bcn_ajuntament @RigauMarina 💬 Mercè de Frias, PhD, MBA, COO @OnaTherapeutics: “At the moment when we got awarded our team was growing. The program helped us consolidate it”.

[Biocat @biocat_en]

@aptadel @Dannabiotech @mimarkdx @zymvol @onechaintx @nmarti1212 @BIOSPAIN_AseBio @PCB_UB @barcelonactiva @bcn_ajuntament @RigauMarina @OnaTherapeutics 💬 Gisela Lorente, CSO @aptadel: “The program allowed us perform our own science and not having to rely that much in external sources”.

[Biocat @biocat_en]

@aptadel @Dannabiotech @mimarkdx @zymvol @onechaintx @nmarti1212 @BIOSPAIN_AseBio @PCB_UB @barcelonactiva @bcn_ajuntament @RigauMarina @OnaTherapeutics 💬 Marina Rigau, CEO & Co-founder @mimarkdx: “I really appreciate the training offered by the program and specially the fact that trains the whole team and to just the C Levels”.

[Biocat @biocat_bioregio]

🔛 El programa #BCNHealthBooster és un èxit!
💬 María Terrades Palomar, CEO del @PCB_UB, ha confirmat a #BIOSPAIN2023 que "veient els indicadors destacats, és hora de començar a pensar en la propera edició del programa".

Més detalls 👇🔗
https://t.co/nE39NCBTcL

[Biocat @biocat_bioregio]

🗣️@nmarti1212 (#Biocat), ha conversat amb les representants de 3 de les startups seleccionades
@OnaTherapeutics, @aptadel i @mimarkdx i ha assegurat que “al llarg dels propers dos anys, seguirem ajudant a les empreses a aconseguir el seu màxim potencial”

[Biocat @biocat_en]

💡 In 2022 the accelerator selected 11 companies having impact projects: @aptadel, @Dannabiotech, Bioliquid Innovative Genetics, SL., deepull, GAT BIOSCIENCES S.L, GAT Therapeutics, @mimarkdx, Nuage Therapeutics, ONA Therapeutics, @zymvol Biomodeling & @onechaintx.

[Biocat @biocat_en]

🔛 #BCNHealthBooster is a success! The program accelerates #health companies by offering access to a lab in the @PCB_UB & training by #Biocat

💬 María Terrades, DG of PCB, said at #BIOSPAIN2023 that "looking at the outstanding indicators, it's time to think in the next edition".

[Barcelona Activa @barcelonactiva]

@montsebasora @PCB_UB Continuem amb una #taularodona moderada per Núria Martí, directora d'innovació de @biocat_cat.

Debatem sobre el potencial del #BCNHealthBooster amb representants i referents del sector:

🔷 @mercedfs d'@OnaTherapeutics
🔷 @RigauMarina de @mimarkdx
🔷 Gisela Lorente d'@aptadel

[BIOSPAIN @BIOSPAIN_AseBio]

@nmarti1212 @biocat_en @OnaTherapeutics 🟢 Marina Rigau @RigauMarina, CEO & Co-founder at @mimarkdx 
🟢 Gisela Lorente, CSO at @aptadel 
🟢 Speakers: María Terrades Palomar , Director of Innovation at @PCB_UB 

📍 Speakers' corner
🕗 11,30 - 12,30
🔗https://t.co/54Cxe5BKw8
#BIOSPAIN2023 #AseBio #health #boost